Peptidase Inhibitors as a Possible Therapeutic Strategy for Chagas Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6662|6|4|183-194

ISSN： 1573-4080

Source： Current Enzyme Inhibition, Vol.6, Iss.4, 2010-01, pp. : 183-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eicosanoid Inhibitors as Therapeutic Targets for Metabolic Syndrome Related Kidney Disease

By  

Current Enzyme Inhibition, Vol. 2, Iss. 1, 2006-02 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Aspartic Peptidase Inhibitors: Implications in Drug Development

By Dash Chandravanu   Kulkarni Aarohi   Dunn Ben   Rao Mala  

Critical Reviews in Biochemistry and Molecular Biology, Vol. 38, Iss. 2, 2003-03 ,pp. : 89-119

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Disulfide Reductases as a Therapeutic Strategy

By  

Current Enzyme Inhibition, Vol. 5, Iss. 3, 2009-01 ,pp. : 117-133

Bentham Science Publishers

Access to resources Recommend Favorite

Silencer elements as possible inhibitors of pseudoexon splicing

By Sironi Manuela  

Nucleic Acids Research, Vol. 32, Iss. 5, 2004-03 ,pp. : 1783-1791

Oxford University Press

Access to resources Recommend Favorite

Aminoacylpyrrolidine-2-nitriles: Potent and Stable Inhibitors of Dipeptidyl-Peptidase IV (CD 26)

By Li J.   Wilk E.   Wilk S.  

Archives of Biochemistry and Biophysics, Vol. 323, Iss. 1, 1995-10 ,pp. : 148-154

Elsevier

Access to resources Recommend Favorite